论文部分内容阅读
目的评价经皮微波凝固治疗TACE术后残留肝癌病灶的疗效。方法对68例TACE术后肝癌残留病灶,在CT引导下对其进行经皮微波凝固治疗。结果68例患者共进行了78次经皮微波凝固治疗,随访3-15个月,肿瘤完全坏死63例(92.65%)。随访期间全部患者均存活,未见明显的副作用和并发症。结论经皮微波凝固治疗可做为肝癌综合治疗中一种安全、有效的治疗方法。
Objective To evaluate the efficacy of percutaneous microwave coagulation in the treatment of residual hepatocellular carcinoma after TACE. Methods Sixty-eight patients with post-TACE residual liver cancer were treated by CT-guided percutaneous microwave coagulation. Results A total of 78 patients underwent percutaneous microwave coagulation therapy in 68 patients. All cases were followed up for 3-15 months. Tumor necrosis completely occurred in 63 cases (92.65%). All patients survived during follow-up, with no apparent side effects and complications. Conclusion Percutaneous microwave coagulation therapy can be used as a safe and effective treatment for hepatocellular carcinoma.